{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:24:03Z","timestamp":1793741043911,"version":"4.6.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejphar.2024.176737","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T22:51:53Z","timestamp":1718059913000},"page":"176737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1\/PGC-1\u03b1 pathway"],"prefix":"10.1016","volume":"977","author":[{"given":"Decheng","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9574-8155","authenticated-orcid":false,"given":"Fengxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejphar.2024.176737_bib1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.ejphar.2024.176737_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"1 Suppl. l","key":"10.1016\/j.ejphar.2024.176737_bib3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176737_bib4","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3390\/nu7064938","article-title":"In vivo protective effects of diosgenin against doxorubicin-induced cardiotoxicity","volume":"7","author":"Chen","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.176737_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175808","article-title":"Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C\/PPAR\u03b1\/CD36 pathway","volume":"952","author":"Chen","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2024.176737_bib6","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/nu14112358","article-title":"11\u03b2-HSD1 inhibitor alleviates non-alcoholic fatty liver disease by activating the AMPK\/SIRT1 signaling pathway","volume":"14","author":"Chen","year":"2022","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.ejphar.2024.176737_bib7","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.3390\/ijms22115528","article-title":"P2Y2R deficiency ameliorates hepatic steatosis by reducing lipogenesis and enhancing fatty acid \u03b2-oxidation through AMPK and PGC-1\u03b1 induction in high-fat diet-fed mice","volume":"22","author":"Dusabimana","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176737_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.ejphar.2024.176737_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2024.176737_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1230783","article-title":"Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses","volume":"14","author":"He","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176737_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","article-title":"Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease","volume":"51","author":"Heeb\u00f8ll","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176737_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2019.04.010","article-title":"Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease","volume":"177","author":"Hern\u00e1ndez-Alvarez","year":"2019","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.ejphar.2024.176737_bib13","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1128\/MCB.24.20.9079-9091.2004","article-title":"Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle","volume":"24","author":"Huss","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176737_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11011-014-9542-3","article-title":"Myeloid-specific deletion of SIRT1 increases hepatic steatosis and hypothalamic inflammation in mice fed a high-fat diet","volume":"29","author":"Jeon","year":"2014","journal-title":"Metab. Brain Dis."},{"issue":"10","key":"10.1016\/j.ejphar.2024.176737_bib15","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176737_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220581","article-title":"Knockout of longevity gene Sirt1 in zebrafish leads to oxidative injury, chronic inflammation, and reduced life span","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejphar.2024.176737_bib17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ejphar.2024.176737_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ejphar.2024.176737_bib19","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbalip.2019.04.010","article-title":"Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8","volume":"1864","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejphar.2024.176737_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-015-0220-7","article-title":"Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma","volume":"8","author":"Lou","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2024.176737_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2020.01.004","article-title":"PGC-1\u03b1 isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments","volume":"34","author":"L\u00e9veill\u00e9","year":"2020","journal-title":"Mol. Metabol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176737_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000320552","article-title":"Long-term high-fat-diet feeding impairs mitochondrial biogenesis in liver of male and female rats","volume":"26","author":"Nadal-Casellas","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"issue":"46","key":"10.1016\/j.ejphar.2024.176737_bib23","doi-asserted-by":"crossref","first-page":"10084","DOI":"10.3748\/wjg.v22.i46.10084","article-title":"Sirtuins and nonalcoholic fatty liver disease","volume":"22","author":"Nassir","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.ejphar.2024.176737_bib24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbabio.2007.07.011","article-title":"Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin","volume":"1767","author":"Petrosillo","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176737_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176737_bib26","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"P\u00e9rez-Carreras","year":"2003","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.ejphar.2024.176737_bib27","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.3390\/ijms23137280","article-title":"Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease","volume":"23","author":"Ramanathan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176737_bib28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","article-title":"Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes","volume":"24","author":"Ricchi","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176737_bib29","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/ijms21041206","article-title":"In steatotic cells, ATP-citrate lyase mRNA is efficiently translated through a cap-independent mechanism, contributing to the stimulation of de novo lipogenesis","volume":"21","author":"Siculella","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2024.176737_bib30","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1271\/bbb.70472","article-title":"Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats","volume":"71","author":"Son","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"24","key":"10.1016\/j.ejphar.2024.176737_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413424","article-title":"It is high time physicians thought of natural products for alleviating NAFLD. Is there sufficient evidence to use them","volume":"22","author":"Tarantino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176737_bib32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/nu7020999","article-title":"6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism","volume":"7","author":"Tzeng","year":"2015","journal-title":"Nutrients"},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2024.176737_bib33","article-title":"Jianpi Shengqing Huazhuo Formula improves abnormal glucose and lipid metabolism in obesity by regulating mitochondrial biogenesis","volume":"319","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2024.176737_bib34","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.biopha.2018.12.039","article-title":"Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol","volume":"110","author":"Xu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.176737_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fphys.2012.00068","article-title":"MicroRNA regulation of SIRT1","volume":"3","author":"Yamakuchi","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2024.176737_bib36","article-title":"Liraglutide alleviates hepatic steatosis and liver injury in T2MD rats via a GLP-1R dependent AMPK pathway","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T19:08:37Z","timestamp":1719688117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924004254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"alternative-id":["S0014299924004254"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176737","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1\/PGC-1\u03b1 pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"176737"}}